Dr. Sandrine Miller-Montgomery is the recently appointed Executive Director of the Center for Microbiome Innovation, led by Dr. Rob Knight at UC San Diego. In this position, she is leading a team focused on fostering and expanding industry and academic collaborations, with the mission of accelerating Microbiome discovery and
creating innovative technologies that will support this emerging but exploding field in the consumer world as well as enabling major clinical breakthroughs.
Previously, she was the leading MO BIO Laboratories, a QIAGEN Company, focusing on nucleic acid purification solutions for challenging samples, such as ones found in Microbiome studies. Prior to heading the MO BIO site, Sandrine was their Director of Sales and Marketing, where she led a team, which consistently grew the business at a rate far superior to the market rate.
She has held Global Marketing Manager positions at large companies such as Abbott Laboratories or Illumina (following the acquisition of Helixis, a start-up which she had join in 2008 to help with
the commercialization of their innovative qPCR platform and their exit strategy). Before Helixis, Sandrine had work for many years at Invitrogen, now part of Thermo Fisher, starting as a bench scientist, then R&D Manager, followed by being one of their first Program Managers and ultimately migrating to the business side as Product
Manager for both qPCR reagents and Reverse Transcriptase portfolio. She came into the USA from France in 2000 to join Genset (now part of EMD Serono), in their R&D department focusing on the identification of Obesity and Diabetes cure
Sandrine received both her Pharm.D and her Ph.D. in Life Science from the University of Bordeaux (France),
with emphasis on molecular biology, biology of aging and thrombosis and hemostasis.